Hypersensitivity reactions to multiple anti-tuberculosis drugs.
Hong Joon ShinJin-Sun ChangMin-Suk KimBo-Gun KohHa-Young ParkTae-Ok KimChul-Kyu ParkIn-Jae OhYu-Il KimSung-Chul LimYoung-Chul KimYoung-Il KohYong Soo KwonPublished in: PloS one (2021)
Multiple anti-TB DHRs were common in all patients who experienced DHRs, and rifampin was the most common causative drug. The treatment outcomes appeared to be poorer in patients with multiple DHRs than in those with single DHRs.